A Double Blind Randomized Controlled of Placebo and Nebulized Lidocaine for Migraine Headache
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
Migraine headaches have previously been shown to be responsive to intranasal lidocaine in a
small study. Using a nebulizer to administer the drug would improve the feasibility of using
the treatment. It would also spare the patient narcotics with their attendant side effects.
Because of the potential for placebo effect a placebo control is necessary in this study.